CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 80 filers reported holding CYMABAY THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $98,000 | -46.7% | 66,400 | -29.2% | 0.01% | 0.0% |
Q4 2019 | $184,000 | -61.2% | 93,829 | 0.0% | 0.01% | -72.2% |
Q3 2019 | $474,000 | -28.5% | 93,829 | +1.3% | 0.02% | -35.7% |
Q2 2019 | $663,000 | -43.0% | 92,638 | +5.8% | 0.03% | -47.2% |
Q1 2019 | $1,163,000 | +68.8% | 87,575 | 0.0% | 0.05% | +76.7% |
Q4 2018 | $689,000 | -29.3% | 87,575 | -0.5% | 0.03% | -41.2% |
Q3 2018 | $975,000 | -17.4% | 88,007 | 0.0% | 0.05% | -48.0% |
Q2 2018 | $1,181,000 | +50.4% | 88,007 | +45.7% | 0.10% | -5.8% |
Q1 2018 | $785,000 | +31.7% | 60,407 | -6.8% | 0.10% | +22.4% |
Q4 2017 | $596,000 | – | 64,800 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 2,023,369 | $27,154,000 | 9.26% |
Omega Fund Management, LLC | 551,477 | $7,401,000 | 5.46% |
Foresite Capital Management III, LLC | 1,562,040 | $20,963,000 | 4.51% |
Versant Venture Management, LLC | 1,048,601 | $14,072,225,000 | 4.39% |
Boxer Capital, LLC | 2,094,000 | $28,101,000 | 3.18% |
Opaleye Management Inc. | 697,500 | $9,360,000 | 2.42% |
Abingworth LLP | 273,417 | $3,667,000 | 2.10% |
DAFNA Capital Management LLC | 294,511 | $3,952,000 | 1.85% |
NEXTHERA CAPITAL LP | 828,655 | $11,121,000 | 1.72% |
Vivo Capital, LLC | 906,000 | $12,158,000 | 1.57% |